Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Consumption of fish products across the lifespan and prostate cancer risk.

Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.

PLoS One. 2013 Apr 17;8(4):e59799. doi: 10.1371/journal.pone.0059799. Print 2013.

2.

The use of genealogy databases for risk assessment in genetic health service: a systematic review.

Stefansdottir V, Johannsson OT, Skirton H, Tryggvadottir L, Tulinius H, Jonsson JJ.

J Community Genet. 2013 Jan;4(1):1-7. doi: 10.1007/s12687-012-0103-3. Epub 2012 Jul 18.

3.

Rye bread consumption in early life and reduced risk of advanced prostate cancer.

Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Adami HO, Gudnason V, Steingrimsdottir L.

Cancer Causes Control. 2012 Jun;23(6):941-50. doi: 10.1007/s10552-012-9965-2. Epub 2012 Apr 25.

4.

Cancer incidence among Nordic airline cabin crew.

Pukkala E, Helminen M, Haldorsen T, Hammar N, Kojo K, Linnersjö A, Rafnsson V, Tulinius H, Tveten U, Auvinen A.

Int J Cancer. 2012 Dec 15;131(12):2886-97. doi: 10.1002/ijc.27551. Epub 2012 Apr 16.

5.

Milk intake in early life and risk of advanced prostate cancer.

Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA.

Am J Epidemiol. 2012 Jan 15;175(2):144-53. doi: 10.1093/aje/kwr289. Epub 2011 Dec 20.

6.

Multigenerational information: the example of the Icelandic Genealogy Database.

Tulinius H.

Methods Mol Biol. 2011;675:221-9. doi: 10.1007/978-1-59745-423-0_11.

PMID:
20949392
7.

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.

J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.

PMID:
17565157
8.

[Hepatocellular carcinoma in Iceland.].

Ragnarsdóttir B, Jónasson JG, Tulinius H, Olafsson S.

Laeknabladid. 2001 Jun;87(6):527-31. Icelandic.

PMID:
17018993
9.

[Liver metastases of unknown origin.].

Halldórsdóttir AM, Agnarsson BA, Tulinius H, Bjarnadóttir K, Jónasson JG.

Laeknabladid. 2000;86(10):661-5. Icelandic.

PMID:
17018956
10.

[The effect of pregnancy on the survival of women diagnosed with breast cancer.].

Birgisson H, Tryggvadóttir L, Tulinius H.

Laeknabladid. 2000 Jul-Aug;86(7-8):495-8. Icelandic.

PMID:
17018939
11.

Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.

Jonsson E, Sigbjarnarson HP, Tomasson J, Benediktsdottir KR, Tryggvadottir L, Hrafnkelsson J, Olafsdottir EJ, Tulinius H, Jonasson JG.

Scand J Urol Nephrol. 2006;40(4):265-71.

PMID:
16916765
12.

Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.

Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Tulinius H, Möller T.

Acta Oncol. 2006;45(4):438-48.

PMID:
16760180
13.

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.

PMID:
16418514
14.

Associations between three types of maternal bacterial infection and risk of leukemia in the offspring.

Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, Hemminki E, Gudnadottir M, Kjartansdottir A, Paavonen J, Pukkala E, Tulinius H, Lehtinen T, Koskela P.

Am J Epidemiol. 2005 Oct 1;162(7):662-7. Epub 2005 Aug 24.

PMID:
16120707
15.

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.

Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

J Med Genet. 2005 Jul;42(7):602-3.

16.

Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.

Ogmundsdóttir HM, Haraldsdóttirm V, Jóhannesson GM, Olafsdóttir G, Bjarnadóttir K, Sigvaldason H, Tulinius H.

Haematologica. 2005 Jan;90(1):66-71.

17.

Risk factors for malignant melanoma in an Icelandic population sample.

Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirsson B, Olafsson JH.

Prev Med. 2004 Aug;39(2):247-52.

PMID:
15226032
18.

Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE).

Langner I, Blettner M, Gundestrup M, Storm H, Aspholm R, Auvinen A, Pukkala E, Hammer GP, Zeeb H, Hrafnkelsson J, Rafnsson V, Tulinius H, De Angelis G, Verdecchia A, Haldorsen T, Tveten U, Eliasch H, Hammar N, Linnersjö A.

Radiat Environ Biophys. 2004 Feb;42(4):247-56. Epub 2003 Nov 28.

PMID:
14648170
19.

Familial risk of prostate cancer in Iceland.

Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H.

BJU Int. 2003 Dec;92(9):915-9.

20.

Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population.

Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirsson B, Olafsson JH.

Occup Environ Med. 2003 Nov;60(11):815-20.

21.

Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland.

Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J.

Occup Environ Med. 2003 Nov;60(11):807-9.

22.

BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE.

Breast Cancer Res. 2003;5(5):R121-8. Epub 2003 Jun 24.

23.

Mortality from cancer and other causes among male airline cockpit crew in Europe.

Blettner M, Zeeb H, Auvinen A, Ballard TJ, Caldora M, Eliasch H, Gundestrup M, Haldorsen T, Hammar N, Hammer GP, Irvine D, Langner I, Paridou A, Pukkala E, Rafnsson V, Storm H, Tulinius H, Tveten U, Tzonou A.

Int J Cancer. 2003 Oct 10;106(6):946-52.

24.

Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring.

Lehtinen M, Koskela P, Ogmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, Hakulinen T, Kjartansdottir A, Kvarnung M, Pukkala E, Tulinius H, Lehtinen T.

Am J Epidemiol. 2003 Aug 1;158(3):207-13.

PMID:
12882942
25.

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709.

26.

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.

Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman AJ, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, Johnson KC, Mao Y, De Sanjosé S, Lee N, Marchbanks P, Ory HW, Peterson HB, Wilson HG, Wingo PA, Ebeling K, Kunde D, Nishan P, Hopper JL, Colditz G, Gajalanski V, Martin N, Pardthaisong T, Silpisornkosol S, Theetranont C, Boosiri B, Chutivongse S, Jimakorn P, Virutamasen P, Wongsrichanalai C, Ewertz M, Adami HO, Bergkvist L, Magnusson C, Persson I, Chang-Claude J, Paul C, Skegg DC, Spears GF, Boyle P, Evstifeeva T, Daling JR, Hutchinson WB, Malone K, Noonan EA, Stanford JL, Thomas DB, Weiss NS, White E, Andrieu N, Brêmond A, Clavel F, Gairard B, Lansac J, Piana L, Renaud R, Izquierdo A, Viladiu P, Cuevas HR, Ontiveros P, Palet A, Salazar SB, Aristizabel N, Cuadros A, Tryggvadottir L, Tulinius H, Bachelot A, Lê MG, Peto J, Franceschi S, Lubin F, Modan B, Ron E, Wax Y, Friedman GD, Hiatt RA, Levi F, Bishop T, Kosmelj K, Primic-Zakelj M, Ravnihar B, Stare J, Beeson WL, Fraser G, Bullbrook RD, Cuzick J, Duffy SW, Fentiman IS, Hayward JL, Wang DY, McMichael AJ, McPherson K, Hanson RL, Leske MC, Mahoney MC, Nasca PC, Varma AO, Weinstein AL, Moller TR, Olsson H, Ranstam J, Goldbohm RA, van den Brandt PA, Apelo RA, Baens J, de la Cruz JR, Javier B, Lacaya LB, Ngelangel CA, La Vecchia C, Negri E, Marubini E, Ferraroni M, Gerber M, Richardson S, Segala C, Gatei D, Kenya P, Kungu A, Mati JG, Brinton LA, Hoover R, Schairer C, Spirtas R, Lee HP, Rookus MA, van Leeuwen FE, Schoenberg JA, McCredie M, Gammon MD, Clarke EA, Jones L, Neil A, Vessey M, Yeates D, Appleby P, Banks E, Beral V, Bull D, Crossley B, Goodill A, Green J, Hermon C, Key T, Langston N, Lewis C, Reeves G, Collins R, Doll R, Peto R, Mabuchi K, Preston D, Hannaford P, Kay C, Rosero-Bixby L, Gao YT, Jin F, Yuan JM, Wei HY, Yun T, Zhiheng C, Berry G, Cooper Booth J, Jelihovsky T, MacLennan R, Shearman R, Wang QS, Baines CJ, Miller AB, Wall C, Lund E, Stalsberg H, Shu XO, Zheng W, Katsouyanni K, Trichopoulou A, Trichopoulos D, Dabancens A, Martinez L, Molina R, Salas O, Alexander FE, Anderson K, Folsom AR, Hulka BS, Bernstein L, Enger S, Haile RW, Paganini-Hill A, Pike MC, Ross RK, Ursin G, Yu MC, Longnecker MP, Newcomb P, Bergkvist L, Kalache A, Farley TM, Holck S, Meirik O; Collaborative Group on Hormonal Factors in Breast Cancer.

Br J Cancer. 2002 Nov 18;87(11):1234-45.

27.

Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.

Baffoe-Bonnie AB, Kiemeney LA, Beaty TH, Bailey-Wilson JE, Schnell AH, Sigvaldason H, Olafsdóttir G, Tryggvadóttir L, Tulinius H.

Genet Epidemiol. 2002 Nov;23(4):349-63.

PMID:
12432503
28.

Risk of cancer among relatives of patients with glioma.

O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):921-4.

29.

Genetic epidemiologic aspects of gastric cancer in Iceland.

Imsland AK, Eldon BJ, Arinbjarnarson S, Egilsson V, Tulinius H, Tryggvadóttir L, Arngrímsson R, Magnússon J.

J Am Coll Surg. 2002 Aug;195(2):181-6; discussion 186-7.

PMID:
12168964
30.

The effect of a single BRCA2 mutation on cancer in Iceland.

Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE.

J Med Genet. 2002 Jul;39(7):457-62.

31.

Monoclonal gammopathy in Iceland: a population-based registry and follow-up.

Ogmundsdóttir HM, Haraldsdóttir V, M Jóhannesson G, Olafsdóttir G, Bjarnadóttir K, Sigvaldason H, Tulinius H.

Br J Haematol. 2002 Jul;118(1):166-73.

PMID:
12100144
32.

[Cancer in siblings of children with cancer].

Winther JF, Sankila R, Boice JD Jr, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Möller T, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH.

Ugeskr Laeger. 2002 Jun 3;164(23):3073-9. Danish.

PMID:
12082866
33.

Breast cancer risk factors and age at diagnosis: an Icelandic cohort study.

Tryggvadóttir L, Tulinius H, Eyfjord JE, Sigurvinsson T.

Int J Cancer. 2002 Apr 1;98(4):604-8.

34.

Helicobacter pylori antibodies and gastric cancer in Iceland - The decline in IgG antibody level is a risk factor.

Tulinius H, Ogmundsdottir HM, Kristinsson KG, Sigvaldason H, Sigvaldadottir E, Kristjansdottir G, Sigfusson N.

APMIS. 2001 Dec;109(12):835-41.

PMID:
11846724
35.

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study.

Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Möller TR, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH.

Lancet. 2001 Sep 1;358(9283):711-7.

PMID:
11551577
36.

Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries.

Möller TR, Garwicz S, Barlow L, Winther JF, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H; Association of the Nordic Cancer Registries; Nordic Society for Pediatric Hematology and Oncology.

J Clin Oncol. 2001 Jul 1;19(13):3173-81.

PMID:
11432883
37.

Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study.

Tryggvadóttir L, Tulinius H, Eyfjord JE, Sigurvinsson T.

Am J Epidemiol. 2001 Jul 1;154(1):37-42.

PMID:
11427403
38.

Familial non-medullary thyroid cancer in Iceland.

Hrafnkelsson J, Tulinius H, Jónasson JG, Sigvaldason H.

J Med Genet. 2001 Mar;38(3):189-91. No abstract available.

39.

Risk of breast cancer in female flight attendants: a population-based study (Iceland).

Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J.

Cancer Causes Control. 2001 Feb;12(2):95-101.

PMID:
11246849
40.

Serum thyroglobulin as a risk factor for thyroid carcinoma.

Hrafnkelsson J, Tulinius H, Kjeld M, Sigvaldason H, Jónasson JG.

Acta Oncol. 2000;39(8):973-7.

PMID:
11207005
41.
42.

Incidence of cancer among commercial airline pilots.

Rafnsson V, Hrafnkelsson J, Tulinius H.

Occup Environ Med. 2000 Mar;57(3):175-9.

43.

Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees.

Baffoe-Bonnie AB, Beaty TH, Bailey-Wilson JE, Kiemeney LA, Sigvaldason H, Olafsdóttir G, Tryggvadóttir L, Tulinius H.

Genet Epidemiol. 2000 Jan;18(1):81-94.

PMID:
10603460
44.

[Adenocarcinoma of the prostate. Familial risk in Icelandic males.].

Jonsson E, Olafsdottir G, Sigvaldason H, Tulinius H.

Laeknabladid. 1999 Sep;85(9):708-10. Icelandic.

PMID:
19439800
45.

Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995.

Tulinius H, Sigvaldason H, Olafsdóttir G, Tryggvadóttir L, Bjarnadóttir K.

J Med Genet. 1999 Feb;36(2):103-7.

46.

Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjörd JE.

Lancet. 1998 Oct 24;352(9137):1337-9.

PMID:
9802270
47.

Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries.

Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, Tulinius H.

Acta Oncol. 1998;37(1):49-59.

PMID:
9572654
48.

Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology.

Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Møller T, Tulinius H.

N Engl J Med. 1998 May 7;338(19):1339-44.

49.

High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands.

Hjalgrim H, Tulinius H, Dalberg J, Hardarson S, Frisch M, Melbye M.

Br J Cancer. 1998 Apr;77(7):1190-3.

50.

[Hormone replacement therapy in Iceland.].

Eliasson JH, Tryggvadottir L, Tulinius H, Gudmundsson JA.

Laeknabladid. 1998 Jan;84(1):25-31. Icelandic.

PMID:
19667427

Supplemental Content

Loading ...
Support Center